Evidence map›Paper›PMID 28799737›Full record

ArticleACS synthetic biology2018

Method to Assemble Genomic DNA Fragments or Genes on Human Artificial Chromosome with Regulated Kinetochore Using a Multi-Integrase System.

Nicholas C O Lee, Jung-Hyun Kim, Nikolai S Petrov, Hee-Sheung Lee, Hiroshi Masumoto, William C Earnshaw, Vladimir Larionov, Natalay Kouprina

Abstract read
In one paragraph

Article in ACS synthetic biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. The design and engineering of synthetic genomes.Nature reviews. Genetics · 2025
    Review
  2. The lives of cells, recorded.Nature reviews. Genetics · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology.Molecular therapy. Methods & clinical development · 2019
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicholas C O LeeDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.ORCID 0000-0003-2628-6599
Jung-Hyun KimDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.
Nikolai S PetrovDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.
Hee-Sheung LeeDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.
Hiroshi MasumotoLaboratory of Cell Engineering, Department of Frontier Research, Kazusa DNA Research Institute , 2-6-7 Kazusa-Kamatari, Kisarazu, Chiba 292-0818, Japan.
William C EarnshawWellcome Trust Centre for Cell Biology, University of Edinburgh , Edinburgh EH9 3JR, Scotland.
Vladimir LarionovDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.
Natalay KouprinaDevelopmental Therapeutics Branch, National Cancer Institute , Bethesda, Maryland 20892, United States.

Funding

Study of hereditary prostate cancer and human artificial chromosomesZIABC010413 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARIONOV, VLADIMIR · 2009 to 2025
$31.5M
LRBGE Optical Microscopy CoreZICBC011574 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KARPOVA, TATIANA · 2014 to 2025
$7.4M
Wellcome Trust 107022
6 · The paper itself

Abstract

The production of cells capable of carrying multiple transgenes to Mb-size genomic loci has multiple applications in biomedicine and biotechnology. In order to achieve this goal, three key steps are required: (i) cloning of large genomic segments; (ii) insertion of multiple DNA blocks at a precise location and (iii) the capability to eliminate the assembled region from cells. In this study, we designed the iterative integration system (IIS) that utilizes recombinases Cre, ΦC31 and ΦBT1, and combined it with a human artificial chromosome (HAC) possessing a regulated kinetochore (alphoid

Indexed as

AnimalsCHO CellsChromosomes, Artificial, HumanCricetinaeCricetulusDNAHumansIn Situ Hybridization, FluorescenceIntegrasesKinetochoresPlasmidsRecombination, GeneticVon Hippel-Lindau Tumor Suppressor ProteinCre recombinaseDNAIntegrasesVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinDNA assemblyHAChuman artificial chromosomeIISiterative integration systemsynthetic biology

Identifiers

PMID28799737
PMCPMC5778389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.